References
- Berry MJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–9
- Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified?. BJU Int 1999; 83: 227–37
- Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and post-operative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 164: 1307–10
- Botto H, Lebret T, Barré P, Orsoni JL, Hervé JM, Lugagne PM. Electrovaporization of the prostate with the Gyrus device. J Endourol 2001; 15: 313–6
- Eaton AC, Francis RN. The provision of transurethral prostatectomy on a day-case basis using bipolar plasma kinetic technology. BJU Int 2002; 89: 534–7
- Patankar S, Jamkar A, Dobhada S, Gorde V. PlasmaKinetic superpulse transurethral resection versus conventional transurethral resection of prostate. J Endourol 2006; 20: 215–9
- Lekas AG, Lazaris AC, Chrisofos M, Papatsoris AG, Lappas D, Patsouris E, et al. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia. Urology 2006; 68: 436–41
- Singh H, Desai MR, Shrivastav P, Vani K. Bipolar versus monopolar transurethral resection of prostate: randomized controlled study. J Endourol 2005; 19: 333–8
- Dincel C, Samli MM, Guler C, Demirbas M, Karalar M. Plasma kinetic vaporization of the prostate: clinical evaluation of a new technique. J Endourol 2004; 18: 293–8
- Wendt-Nordahl G, Häcker A, Fastenmeier K, Knoll T, Reich O, Alken P, et al. New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation. J Endourol 2005; 19: 1203–9